CEO said this half year will kill (to the good) the prior years,...

CEO said this half year will kill (to the good) the prior years, corresponding half year. Yet, that half year (a year ago) was so, so low. They 'said' they made it low on purpose (at the time) to put all their efforts into product ramp up. That, is they did not do hardly any services to spend that effort manufacturing FebriDx. Yet, FebriDx did not sell hardly any over the next 6 months.

So, you dont know if they are just chatter boxes explaining away.

Anyway, the prior Q (Q1 2025) was, on its own, way over the half year... that is 3.4 mill revenue 2025 Q1 vs 2.7 mill revenue (2024 Q1 PLUS Q2). So for Doug to say 'oh, the upcoming half yearly will be amazing (compared to the half year the prior year) is just rubbish talk. He just hopes no one knows the stories and smoke and mirrors and excuses they pulled out of their hat before.

Mind you, Mr Market is a bit stupid, so if they see a 300% increase in revenue, maybe they fall for the three card trick. That is, 2.7 mill to $7+ mill.

But yes, the 'eye of the beholder' is keen if you are a trader. For us long termers we hope for product sales and cash flow positive (no matter how they smoke and mirror it)